For the quarter ending 2026-03-31, CLNE had -$100,099K decrease in cash & cash equivalents over the period. -$15,256K in free cash flow.
| Cash Flow | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Loss on extinguishment of debt | - | -11,515 | - | - |
| Net loss | -12,527 | -43,194 | -24,003 | -155,439 |
| Extinguishment of unamortized discount on expiration of deferred drawdown | - | 14,681 | -1,136 | -2,285 |
| Depreciation and amortization | 11,002 | 11,695 | 14,682 | 72,229 |
| Provision for credit losses and inventory | 138 | 928 | 2,088 | 991 |
| Stock-based compensation expense | 2,030 | 2,496 | 2,193 | 4,180 |
| Stock-based sales incentive charges | 10,107 | 14,591 | 16,776 | 34,734 |
| Change in fair value of derivative instruments | 616 | -244 | -319 | -1,101 |
| (gain)/loss on sale of btr equity and convertible promissory note | 0 | 0 | 2,058 | - |
| Amortization of debt financing costs | 1,144 | 1,317 | 1,388 | 2,589 |
| Amortization of discounts and section 30c tax credit | -470 | -4,162 | - | - |
| Asset impairments and other charges | - | 0 | - | - |
| Loss on disposal of property and equipment | -145 | 3 | 81 | -2,791 |
| Impairment of goodwill | 0 | 0 | 0 | 64,328 |
| Impairment of investments in equity securities | - | 0 | - | - |
| Loss from equity method investments | -5,638 | -5,639 | -7,524 | -13,574 |
| Non-cash lease expense | 2,322 | 3,144 | 2,094 | 3,779 |
| Deferred income taxes | 0 | -22 | 51 | -2,905 |
| Accretion of aro liabilities | 92 | 89 | 102 | 202 |
| Accounts and other receivables | 9,046 | 19,845 | 13,014 | -30,071 |
| Inventory | -756 | 728 | 942 | 2,765 |
| Prepaid expenses and other assets | 422 | -2,337 | -499 | 551 |
| Operating lease liabilities | -2,364 | -2,931 | -1,648 | -3,823 |
| Accounts payable | -3,897 | -151 | 4,639 | -6,078 |
| Deferred revenue | -2,873 | 7,974 | 1,575 | 1,927 |
| Accrued liabilities and other | -9,521 | 7,498 | 2,040 | 679 |
| Net cash provided by (used in) operating activities | -8,362 | 13,112 | 13,088 | 59,329 |
| Purchases of short-term investments | 159,999 | 167,014 | 166,755 | 520,812 |
| Advance to dr jv | - | 0 | - | - |
| Maturities and sales of short-term investments | 90,242 | 218,483 | 225,213 | 542,325 |
| Proceeds from repayment of advance by dr jv | - | 0 | - | - |
| Proceeds from settlement of insurance claims | - | 0 | 0 | 0 |
| Payment and deposits on equipment and manure rights for adg rng production projects | 178 | 7,794 | 5,560 | 20,851 |
| Purchases of and deposits on property and equipment | 6,894 | 6,612 | 6,620 | 12,447 |
| Grant proceeds for capital projects | - | 0 | 0 | 0 |
| Proceeds received for joint development and construction of station projects | 453 | 333 | 536 | 2,490 |
| Disbursements for loans receivable | 0 | 900 | 700 | 2,400 |
| Proceeds from paydowns, maturities, and sales of loans receivable | 21 | 21 | 3,483 | 40 |
| Investments in other entities | 13,271 | 3,480 | 13,008 | 0 |
| Fees paid for lender and debt issuance costs | - | 0 | 0 | 0 |
| Proceeds from disposal of property and equipment | 16 | 31 | 89 | 5,008 |
| Proceeds for adopt-a-port program | - | 0 | 0 | 465 |
| Net cash provided by (used in) provided by investing activities | -89,610 | 33,068 | 36,678 | -6,647 |
| Issuance of common stock | 0 | -93 | 4 | 52 |
| Repurchase of common stock | 0 | 0 | 0 | 7,938 |
| Payment of tax withholdings on net settlement of equity awards | 1,210 | 0 | 1 | 498 |
| Repayment of proceeds for adopt-a-port program | 404 | 368 | 473 | 1,708 |
| Proceeds from debt instruments | - | 0 | - | - |
| Repayments of debt instruments and finance lease obligations | 336 | 346 | 297 | 574 |
| Repayment of stonepeak debt | - | 65,000 | - | - |
| Payments of debt extinguishment costs | - | 5,336 | - | - |
| Net cash (used in) financing activities | -1,950 | -71,143 | -767 | -10,201 |
| Effect of exchange rates on cash, cash equivalents and restricted cash | -177 | -236 | -247 | 160 |
| Net increase in cash, cash equivalents and restricted cash | -100,099 | -25,199 | 48,752 | 42,641 |
| Cash, cash equivalents and restricted cash, beginning of period | 157,756 | 182,955 | 91,562 | - |
| Cash, cash equivalents and restricted cash, end of period | 57,657 | 157,756 | 182,955 | - |